Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J M, Kamradt"'
Publikováno v:
The Prostate. 44(4)
Estramustine in combination with other chemotherapeutic agents has demonstrated synergy in hormone-refractory prostate cancer. Docetaxel has demonstrated antineoplastic activity in a variety of chemotherapeutic-unresponsive tumors. We evaluated the e
Autor:
J M, Kamradt, K J, Pienta
Publikováno v:
Seminars in oncology. 26(2)
The treatment options available for advanced prostate cancer are increasing. These improved therapies are the result of research involving cellular targets other than DNA proliferation. For example, therapy directed against the intracellular matrix h
Publikováno v:
Cancer metastasis reviews. 17(4)
Publikováno v:
The Urologic clinics of North America. 26(2)
The use of oral chemotherapy for the treatment of malignant disease is expanding. The authors' experience with oral chemotherapy for hormone-refractory prostate cancer continues to grow. These therapies are well-tolerated and effective. Already, thes
Publikováno v:
The Urologic clinics of North America. 26(2)
The role of chemotherapy in the management of advanced prostate cancer is expanding. Multiple regimens that use a variety of drugs have been developed. A chemotherapy regimen may appear to be a collection of randomly chosen agents. This article prese
Publikováno v:
Anticancer research. 18(6A)
Many chemotherapeutic agents are believed to kill cancer cells by inflicting cellular damage which triggers the cell to enter apoptosis (programmed cell death). We investigated the means by which carboplatin induces cell death in three model cancer s
Autor:
D I, Allen, J M, Kamradt
Publikováno v:
The Journal of family practice. 33(6)
Projects that are currently under way in Indiana to improve access to obstetrical care have not addressed the availability of these services in nonmetropolitan areas. This study was designed to identify all physicians who were providing obstetrical s